RS

Raspreet Singh

Director Director DIN 01049571
DIN 01049571 First appointment Mar 2005 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2005
Shareholding value Locked Premium profile

About Raspreet Singh

Data last updated:

Raspreet Singh has 21 years in corporate governance. Formerly with 1 company, such as Cris Pharma (India) Limited. Engaged in General Business. Contributes to corporate operations.

DIN 01049571
Primary Designation Director
First Appointment 20 Mar 2005
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Cris Pharma (India) Limited U24139RJ1992PLC034757
Director20 Mar 20051992Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cris Pharma (India) Limited
Premium access

Shareholding and investment profile for Raspreet Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raspreet Singh

Raspreet Singh has 21 years in corporate governance. Formerly with 1 company, such as Cris Pharma (India) Limited. Engaged in General Business. Contributes to corporate operations.

Raspreet Singh is associated with 0 companies as a director.

Raspreet Singh has expertise in General Business.

Raspreet Singh has 21 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available